The startup develops novel respiratory devices designed to enhance the management of asthma and emergency medical situations through advanced therapeutic delivery systems. These devices aim to improve patient outcomes by providing precise medication dosing and real-time monitoring of respiratory conditions.
Funding
$50M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current respiratory devices often lack precise medication dosing and real-time monitoring capabilities, hindering effective management of asthma and other emergency respiratory conditions. This can lead to suboptimal patient outcomes due to inaccurate drug delivery and delayed response to changing respiratory status.
Solution
The company develops advanced respiratory devices that enhance the management of asthma and emergency medical situations through improved therapeutic delivery systems. These devices focus on providing precise medication dosing and real-time monitoring of respiratory conditions. The product line includes solutions for therapeutics, COVID-19 supplies, and emergency medical applications. The devices are designed to improve patient outcomes by ensuring accurate drug delivery and enabling timely intervention based on real-time respiratory monitoring.
Target Audience
The primary target audience includes patients with asthma, healthcare providers in emergency medical settings, and individuals requiring respiratory support during COVID-19 or other respiratory illnesses.
Features
- Precise medication dosing for optimal therapeutic effect.
- Real-time monitoring of respiratory parameters.
- Devices for asthma management.
- Solutions for emergency medical situations.
- Product offerings include COVID-19 supplies and PPE.